Evidence map›Paper›PMID 34793697›Full record

ArticleAmerican journal of human genetics2021

Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN.

Shawn Fayer, Carrie Horton, Jennifer N Dines, Alan F Rubin, Marcy E Richardson, Kelly McGoldrick, Felicia Hernandez, Tina Pesaran, Rachid Karam, Brian H Shirts and 2 more

Abstract read
In one paragraph

Article in American journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Rescuing the Function of Missense-Mutated Tumor SuppressorbioRxiv : the preprint server for biology · 2026
    Article
  7. Not Forgotten: Patient Experiences with Genetic Variant Reclassifications.medRxiv : the preprint server for health sciences · 2026
    Article
  8. Supervised learning of protein variant effects across large-scale mutagenesis datasets.Protein science : a publication of the Protein Society · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. A scalable approach to resolving variants of uncertain significance.bioRxiv : the preprint server for biology · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Mapping the Functional Landscape ofmedRxiv : the preprint server for health sciences · 2025
    Article
  19. Evidence forbioRxiv : the preprint server for biology · 2025
    Article
  20. MaveMD: A functional data resource for genomic medicine.medRxiv : the preprint server for health sciences · 2025
    Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shawn FayerDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Carrie HortonAmbry Genetics, Aliso Viejo, CA 92656, USA.
Jennifer N DinesDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Alan F RubinBioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Melbourne, VIC 3010, Australia.
Marcy E RichardsonAmbry Genetics, Aliso Viejo, CA 92656, USA.
Kelly McGoldrickAmbry Genetics, Aliso Viejo, CA 92656, USA.
Felicia HernandezAmbry Genetics, Aliso Viejo, CA 92656, USA.
Tina PesaranAmbry Genetics, Aliso Viejo, CA 92656, USA.
Rachid KaramAmbry Genetics, Aliso Viejo, CA 92656, USA.
Brian H ShirtsBrotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
Douglas M FowlerDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Department of Bioengineering, University of Washington, Seattle, WA 98195, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA. Electronic address: dfowler@uw.edu.
Lea M StaritaDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA. Electronic address: lstarita@uw.edu.

Funding

INTERDISCIPLINARY TRAINING IN GENOMIC SCIENCEST32HG000035 · NHGRI · UNIVERSITY OF WASHINGTON · PI Bruce Colston Trapnell · 1995 to 2026
$24.2M
Technology to understand genetic variant effects in contextRM1HG010461 · NHGRI · UNIVERSITY OF WASHINGTON · PI Douglas M Fowler, Bruce Colston Trapnell · 2019 to 2026
$18.9M
Federated Analysis in Cancer Genomics: Surveying the Social, Ethical, and Regulatory LandscapeU01CA242954 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI CLINE, MELISSA SUZANNE · 2019 to 2021
$1.5M
NCI NIH HHS U01 CA242954NHGRI NIH HHS RM1 HG010461NHGRI NIH HHS T32 HG000035
6 · The paper itself

Abstract

Clinical interpretation of missense variants is challenging because the majority identified by genetic testing are rare and their functional effects are unknown. Consequently, most variants are of uncertain significance and cannot be used for clinical diagnosis or management. Although not much can be done to ameliorate variant rarity, multiplexed assays of variant effect (MAVEs), where thousands of single-nucleotide variant effects are simultaneously measured experimentally, provide functional evidence that can help resolve variants of unknown significance (VUSs). However, a rigorous assessment of the clinical value of multiplexed functional data for variant interpretation is lacking. Thus, we systematically combined previously published BRCA1, TP53, and PTEN multiplexed functional data with phenotype and family history data for 324 VUSs identified by a single diagnostic testing laboratory. We curated 49,281 variant functional scores from MAVEs for these three genes and integrated four different TP53 multiplexed functional datasets into a single functional prediction for each variant by using machine learning. We then determined the strength of evidence provided by each multiplexed functional dataset and reevaluated 324 VUSs. Multiplexed functional data were effective in driving variant reclassification when combined with clinical data, eliminating 49% of VUSs for BRCA1, 69% for TP53, and 15% for PTEN. Thus, multiplexed functional data, which are being generated for numerous genes, are poised to have a major impact on clinical variant interpretation.

Indexed as

Genetic TestingMutation, MissenseAdultBRCA1 ProteinData CollectionDatasets as TopicGenetic Association StudiesHumansMedical History TakingPhenotypePredictive Value of TestsPTEN PhosphohydrolaseTumor Suppressor Protein p53BRCA1 ProteinBRCA1 protein, humanPTEN PhosphohydrolasePTEN protein, humanTP53 protein, humanTumor Suppressor Protein p53BRCA1functional dataMAVEPTENTP53variant interpretation

Identifiers

PMID34793697
PMCPMC8715144

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.